Cargando…

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and represents the hepatic expression of several metabolic abnormalities of high epidemiologic relevance. Fat accumulation in the hepatocytes results in cellular fragility and risk of progression toward necroinflammati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Ciaula, Agostino, Passarella, Salvatore, Shanmugam, Harshitha, Noviello, Marica, Bonfrate, Leonilde, Wang, David Q.-H., Portincasa, Piero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160908/ https://www.ncbi.nlm.nih.gov/pubmed/34065331 http://dx.doi.org/10.3390/ijms22105375

Ejemplares similares

Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests
por: Di Ciaula, Agostino, et al.
Publicado: (2021)

Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
por: Di Ciaula, Agostino, et al.
Publicado: (2022)

Intestinal Barrier and Permeability in Health, Obesity and NAFLD
por: Portincasa, Piero, et al.
Publicado: (2021)

Current Views on Genetics and Epigenetics of Cholesterol Gallstone Disease
por: Di Ciaula, Agostino, et al.
Publicado: (2013)

Self-reported symptoms after COVID-19 vaccination. Distinct sex, age, and geographical outcomes in Lebanese and Italian cohorts
por: Khalil, Mohamad, et al.
Publicado: (2023)

The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease
por: Di Ciaula, Agostino, et al.
Publicado: (2023)

Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF)
por: Di Ciaula, Agostino, et al.
Publicado: (2020)

Contribution of the microbiome for better phenotyping of people living with obesity
por: Di Ciaula, Agostino, et al.
Publicado: (2023)

Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations
por: Portincasa, Piero, et al.
Publicado: (2023)

Gender-dependent impact of COVID-19 lockdown on metabolic and psychological aspects
por: Bonfrate, Leonilde, et al.
Publicado: (2023)

Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis
por: Portincasa, Piero, et al.
Publicado: (2022)

Dynamic carbon 13 breath tests for the study of liver function and gastric emptying
por: Bonfrate, Leonilde, et al.
Publicado: (2015)

Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
por: Di Ciaula, Agostino, et al.
Publicado: (2020)

Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling
por: Di Ciaula, Agostino, et al.
Publicado: (2022)

Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis
por: Di Palo, Domenica Maria, et al.
Publicado: (2020)

((13)C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle
por: Molina-Molina, Emilio, et al.
Publicado: (2020)

Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?
por: Oliveira, Paulo J., et al.
Publicado: (2012)

A novel therapeutic effect of statins on nephrogenic diabetes insipidus
por: Bonfrate, Leonilde, et al.
Publicado: (2015)

Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms
por: Mitten, Emilie K., et al.
Publicado: (2023)

Irritable bowel syndrome and diet
por: Portincasa, Piero, et al.
Publicado: (2017)

Use of GELSECTAN(®) in Patients with Irritable Bowel Syndrome (IBS): an Italian Experience
por: Bellini, Massimo, et al.
Publicado: (2021)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
por: Carulli, Lucia, et al.
Publicado: (2019)

Recent advances in understanding and managing cholesterol gallstones
por: Di Ciaula, Agostino, et al.
Publicado: (2018)

Relationships between emissions of toxic airborne molecules and type 1 diabetes incidence in children: An ecologic study
por: Di Ciaula, Agostino, et al.
Publicado: (2021)

A Pleiotropic Role for the Orphan Nuclear Receptor Small Heterodimer Partner in Lipid Homeostasis and Metabolic Pathways
por: Garruti, Gabriella, et al.
Publicado: (2012)

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study
por: Vitellio, Paola, et al.
Publicado: (2019)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Role of Mitochondria in Nonalcoholic Fatty Liver Disease
por: Nassir, Fatiha, et al.
Publicado: (2014)

Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease
por: de Bari, Ornella, et al.
Publicado: (2012)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?
por: Singh, Shivaram P., et al.
Publicado: (2021)

Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
por: Fang, Tingyu, et al.
Publicado: (2022)

Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories
por: Kantartzis, Konstantinos, et al.
Publicado: (2023)

Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians
por: Portincasa, Piero, et al.
Publicado: (2016)

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
por: Younossi, Zobair M., et al.
Publicado: (2023)

Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
por: Chen, Qian, et al.
Publicado: (2017)

Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in Pparg-Null Mice
por: Schiffrin, Mariano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_omvnkiqmhib00eca1qubuu7et5